rosuvastatin / Generic mfg. 
Welcome,         Profile    Billing    Logout  

156 Trials

   

Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
rosuvastatin / Generic mfg.
ACTRN12613000031763: Statin Therapy in Ischemia-Reperfusion Injury during coronary artery bypass grafting.

Not yet recruiting
4
100
 
South Australian Health and Medical Research Institute, South Australian Health and Medical Research Institute
Post CABG ischemia reperfusion injury (IRI)
 
 
ACTRN12612000663853: Does Metformin potentiate the effect of Rosuvastatin therapy on biochemical markers in Patients with Polycystic Ovary Syndrome?

Recruiting
4
54
 
American University of Beirut, American University of Beirut
Polycystic ovary syndrome (PCOS)
 
 
ACTRN12612000732886: Rosuvastatin versus Protease Inhibitor Switching for Hypercholesterolaemia in HIV-infected Adults.

Recruiting
4
60
 
St. Vincent's Hospital, Sydney
Hypercholesterolaemia associated with ritonavir-boosted protease inhibitor therapy in of HIV-infected adults
 
 
ChiCTR-ONC-10001058: Effect of Variant Alleles SLCO1B1 and ABCG2 on Pharmacokinetics of Rosuvastatin in Healthy Volunteers

Completed
4
25
 
collect blood sample
Institute of Clinical Pharmacology, Central South University; Level of the institution:, Self-funding
hyperlipemia
 
 
ChiCTR-TRC-10001085: Effect of Rosuvastatin on Coronary Atheroma in diffused Coronary Artery Disease

Completed
4
400
 
Rosuvastatin ;Atorvastatin
Second affiliated Hospital of Third Military Medical University; Second affiliated Hospital of Third Military Medical University, Second affiliated Hospital of Third Military Medical University
Diffused Coronary Artery Disease
 
 
ChiCTR-TRC-13003691: Berberine Chloride Stabilizes Coronary Atherosclerotic Plaques in Clinical Research

Completed
4
120
 
Rosuvastatin+Berberine ;Rosuvastatin
Xin Hua Hospital Affiliated to Shanghai Jiao Tong University School of Medicine; Xin Hua Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai Traditional Chinese Medicine Development of the Three-year Action Plan
coronary heart disease
 
 
ChiCTR-ONC-14004265: A study to evaluate the effect of intensive statin on subclinical atherosclerosis lesions by intravascular ultrasound

Completed
4
30
 
rosuvastatin 20mg
Cardiovascular Department, Beijing Friendship Hospital; Beijing Friendship Hospital, Capital clinical characteristic applied research
acute coronary syndrome
 
 
2005-002777-68: The effects of rosuvastatin therapy on glucose metabolism in non-diabetic renal transplant recipients with a focus on insulin sensitivity and pancreatic beta islet cell function

Ongoing
4
20
Europe
Crestor, Crestor, Crestor
Cardiff and Vale NHS Trust
New-onset diabetes after transplantation
 
 
2006-006219-56: A multicentre, double-blind, randomised, parallel-group study to evaluate the efficacy, safety and tolerability of ezetimibe/simvastatin 10/40mg, atorvastatin 40mg, and rosuvastatin 10mg to achieve an LDL-C level of <2mmol/l in patients with established CVD or at “high risk” of developing CVD, currently treated with simvastatin 40mg and with a fasting LDL-C 2 mmol/l

Ongoing
4
800
Europe
Inegy, Crestor, Lipitor, Inegy, Crestor, Lipitor
Merck & Co Inc.,
Primary Hypercholesterolaemia
 
 
2007-000151-33: Does caffeine reduce rosuvastatin-induced protection against ischemia-reperfusion injury?

Ongoing
4
24
Europe
Rosuvastatin, Crestor, Crestor
UMCN
Rosuvastatin is a proven cholesterol lowering medicine. Apart from it’s cholesterol lowering action, rosuvastatin may also increase tolerance against ischemia-reperfusion injury. We hypothesize that rosuvastatin increases tolerance against ischemia-reperfusion injury by induction of ecto-5’-nucleotidase and thereby increasing adenosine activity.This protective effect of rosuvastatin can be abbrogated by using the adenosine receptor antagonist caffeine.
 
 
2007-005546-20: Systemic effects of mild renal insufficiency: the relation between forearm blood flow and ADMA.

Ongoing
4
60
Europe
Rosuvastatine, Olmetec, ZD4522, Crestor, Olmetec, Crestor, Olmetec
academisch ziekenhuis Maastricht
hypertensionmild renal insufficiency
 
 
2008-005985-30: Is augmentation of PORH by rosuvastatin adenosine-receptor mediated?

Ongoing
4
8
Europe
caffeine, Crestor, Caffeine, Crestor, Caffeine
Department of Pharmacology-Toxicology
mechanism of influence of statins on human adaptive mechanisms in hypoxic circumstances
 
 
2007-004894-25: Effect of rosuvastatin on cardiovascular events and mortality after pneumonia

Ongoing
4
670
Europe
Crestor, Crestor
Karolinska University Hospital Huddinge
Community aquired pneumonia
 
 
2009-014831-18: Short term statin treatment and endothelial dysfunction due to ischemia and reperfusion injury

Ongoing
4
48
Europe
rosuvastatin, atorvastatin, rosuvastatin, lipitor, rosuvastatin, lipitor
RUNMC
ischemia and reperfusion injuryendothelial dysfunction
 
 
2009-011291-29: RACE 3 study: Intensive vs. usual rhythm control for atrial fibrillation.

Ongoing
4
250
Europe
eplerenone, Spironolactone, atorvastatin, Fluvastatin, Pravastatin, rosuvastatin, Simvastatin, eplerenone, spironolactone, atorvastatin, Fluvastatin, Pravastatin, rosuvastatin, Simvastatin, eplerenone, spironolactone, atorvastatin, Fluvastatin, Pravastatin, rosuvastatin, Simvastatin
Interuniversity Cardiology Institute of the Netherlands (ICIN), Interuniversity Cardiology Institute Netherlands, The Interuniversity Cardiology Institute of the Netherlands (ICIN), Netherlands Heart Foundation (NHS B 2008 035), Working group on Cardiovascular Research, the Netherlands, Sanofi Aventis, Boehringer Ingelheim, Medtronic, Biotronik, St Jude Medical, Boston Scientific, AstraZenenca, Interuniversity Cardiology Institute Netherlands, Working group on Cardiovascular Research, Astra Zeneca, Bayer
atrial fibrillation
 
 
ChiCTR-IPR-15005761: The effects and mechanism of statins on Glucose metabolism in elderly patients with atherosclerotic cardiovascular disease

Recruiting
4
300
 
Atorvastatin calcium ;Atorvastatin calcium ;Rosuvastatin calcium ;Rosuvastatin calcium ;Pitavastatin calcium ;Pitavastatin calcium
Second Department of Cadre Ward, General Hospital of Jinan Military Region; General Hospital of Jinan Military Region, PLA GeneralLogistics Department of the Ministry of health care of special research projects(14BJZ27)
atherosclerotic cardiovascular disease
 
 
2016-003457-15: Delaying progression of arterial disease

Ongoing
4
350
RoW
Rosuvastatin Krka, Tablet, Rosuvastatin Krka
Icelandic Heart Association, Icelandic Heart Association
Atherosclerosis, Subclinical atherosclerosis of the carotid arteries, Diseases [C] - Cardiovascular Diseases [C14]
 
 
NCT01816997: The Statins on Glucose Homeostasis in Subjects With Impaired Fasting Glucose

Recruiting
4
160
RoW
Pravastatin, Pravastatin (Mevalotin), Rosuvastatin, Crestor, Control, placebo
Taipei Veterans General Hospital, Taiwan
Diabetes
12/17
12/22
ChiCTR-OPC-16009540: Pharmacoeconomics of rosuvastatin in improving intracranial hemodynamics in patients with intracranial atherosclerotic stenosis, a case records based study

Recruiting
4
50
 
intensified dose of rosuvastatin (20 mg/day, 52 weeks) versus standard dose of rosuvastatin (10 mg/day, 52 weeks)
The Second Affiliated hospital of Zhejiang University School of Medicine; The Second Affiliated hospital of Zhejiang University School of Medicine, self-funding
Intracranial atherosclerotic stenosis
 
 
ChiCTR-IPR-15007184: Effect of Rosuvastatin Therapy on HDL2 Level andAntiatherosclerotic Reverse Cholesterol Transport Process in Chinses CAD patients with hyperlipidemia

Not yet recruiting
4
300
 
rosuvastatin
Daping Hospital, Third Military Medical University; Daping Hospital, Externally Sponsored Scientific Research
Coronary heart disease (CHD).hyperlipidemia
 
 
ChiCTR-IPR-17011827: Effects of rosuvastatin combined with garlic extract on patients of pulmonary hypertension: A random, controlled trial.

Recruiting
4
120
 
rosuvastatin oral based on routine treatment ;garlic extract oral based on routine treatment ;rosuvastatin combined with garlic extract oral based on routine treatment
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology; Key Laboratory of Pulmonary Diseases of Ministry of Health, Tongji Medical College, Huazhong University of Science and Technology, Natural Science Foundation of China; State key research and development plan
pulmonary hypertension
 
 
2018-003837-13: Statin effect on atheroma calcification

Not yet recruiting
4
44
Europe
Rosuvastatin, Film-coated tablet, Crestor
Centro Hospitalar e Universitário de Coimbra, E.P.E., Astrazeneca-Produtos Farmacêuticos, Lda
Atherosclerosis, namely in the aorta, carotid and coronary arteries, Cardiovascular disease, Diseases [C] - Cardiovascular Diseases [C14]
 
 
ChiCTR1900027173: Therapeutic effect of rosuvastatin on metabolic syndrome in patients with bipolar disorder

Recruiting
4
120
 
Atorvastatin and Behavioral Interventions ;Behavioral Interventions
Hefei Fourth People's Hospital; Hefei Fourth People's Hospital, Pathogenesis of bipolar disorder based on singlecell multi-omics, imaging and cognitive function
Bipolar disorder
 
 
ASTRO-CHF, NCT05072054: Comparison of Effects of Atorvastatin Versus Rosuvastatin on Cardiac Function in Heart Failure Patients

Recruiting
4
80
RoW
Atorvastatin Oral Tablet, Rosuvastatin Oral Tablet
Postgraduate Institute of Medical Education and Research, Indian Council of Medical Research
Heart Failure With Reduced Ejection Fraction
06/22
08/22
NCT03988101: Role of Statin in Venous Dysfunction in Patients With Venous Thromboembolism Event

Recruiting
4
100
RoW
Rosuvastatin 20mg, Control
Yonsei University
Venous Thromboembolism, Dyslipidemias
11/22
11/22
DESIFOR, NCT03889314: The DEtermining Statin Intolerance FOr Rosuvastatin () Trial

Active, not recruiting
4
25
US
Rosuvastatin 20mg, Placebo
Minneapolis Heart Institute Foundation
Cardiovascular Risk Factor, Cardiovascular Diseases, Adverse Effect
12/22
12/22
ChiCTR2100043102: Efficacy and safety of rosuvastatin combined with Shouhui Tongbian capsule in the treatment of dyslipidemia: a prospective, single-center, open, randomized controlled study

Recruiting
4
40
 
Rosuvastatin calcium tablet + Shouhui tongbei capsule ;Rosuvastatin calcium tablet
Beijing Friendship Hospital Affiliated to Capital Medical University; Beijing Friendship Hospital Affiliated to Capital Medical University, Lunan Houpu Pharmaceutical Co., Ltd
Dyslipidemia
 
 
NCT06273215: Evaluation of the Pharmacokinetics of Microdose Midazolam, Dabigatran, Pitavastatin, Atorvastatin and Rosuvastatin in Diabetic Patients

Recruiting
4
48
RoW
The combinations of 10 µg midazolam, 375 µg dabigatran etexilate, 10 µg pitavastatin, 50 µg rosuvastatin, and 100 µg atorvastatin were administered to diabetic patients on an empty stomach.
Peking University Third Hospital
Diabetes
12/25
12/25
ChiCTR2200057751: Evaluation of the efficacy of rosuvastatin combined with cardiac oral solution in the treatment of patients with dyslipidemia with elevated lipoprotein (a)

Recruiting
4
100
 
On the basis of rosuvastatin, Xintong oral solution was combined ;Suvastatin calcium tablets
Liaoning Provincial Health Industry Group Ben'gang General Hospital; Liaoning Provincial Health Industry Group Ben'gang General Hospital, Lunanbet Pharmaceuticals Ltd.
Dyslipidemia with elevated lipoprotein (a)
 
 
ChiCTR2200057772: Short-term evaluation of modified, low-dose PCSK9 inhibitors combined with statins in the treatment of acute coronary syndrome dyslipidemia in Chinese

Not yet recruiting
4
100
 
receive medium-dose statin daily(atorvastatin 20mg qn or rosuvastatin 10mg qn) ;receive medium-dose statin daily(atorvastatin 20mg qn or rosuvastatin 10mg qn)+once a month, subcutaneous injection of 1 injection of PCSK9 inhibitor each time ;receive medium-dose statin daily(atorvastatin 20mg qn or rosuvastatin 10mg qn)+twice a month, subcutaneous injection of 1 injection of PCSK9 inhibitor each time
The First Affiliated Hospital of Nanjing Medical University; Jiangsu Provincial People's Hospital, Self-funded
acute coronary syndrome
 
 
EMERALD, NCT05742841: (Emergency Medicine Cardiovascular Risk Assessment for Lipid Disorders)

Completed
4
22
US
moderate- or high-intensity statin/ rosuvastatin, Crestor
Wake Forest University Health Sciences
Lipid Disorder
06/23
07/23
ChiCTR2200062305: Mr-VPD evaluation of PCSK9i in patients with intracranial atherosclerotic stenosis

Recruiting
4
100
 
PCSK9iatorvastatin calcium 20mg/ rosuvastatin calcium 10mg; atorvastatin calcium 20mg/ rosuvastatin calcium 10mg
The Second Affiliated Hospital of the Army Medical University; The Second Affiliated Hospital of the Army Medical University, The patient's normal medical treatment process, examination fees and drug costs shall be borne by themself.
Cerebral vascular disease
 
 
NCT06053983: Comparison Between Atorvastatin and Rosuvastatin in Reduction of Inflammatory Biomarkers in Patients With Acute Coronary Syndrome

Completed
4
126
RoW
Turbox CRP kit, rosuvastatin 20 mg,, atorvastatin 40 mg
Rawalpindi Medical College
Mi Q Wave
08/23
08/23
WARRIOR, NCT03417388: Women's IschemiA TRial to Reduce Events In Non-ObstRuctive CAD

Active, not recruiting
4
2476
US
High dose potent statin, atorvastatin or rosuvastatin, ACE-I (lisinopril) or ARB (losartan), ACE-I or ARB, Aspirin, Lifestyle Counseling, PACE Lifestyle Intervention, Quality of Life Questionnaires, QOL
University of Florida, United States Department of Defense
Coronary Artery Disease
09/24
12/24
PETARDS, NCT05658692: Platform Adaptive Embedded Trial for Acute Respiratory Distress Syndrome

Recruiting
4
1000
RoW
protective ventilation, prone position ventilation, glucocorticoid therapy, Dexamethasone, Hydrocortisone, restrictive fluid resuscitation, Thymosin Alpha, Muscle relaxant therapy, Vecuronium Bromide, Succinylcholine, Integrated Chinese and Western Medicine Treatment, statin therapy, Simvastatin, Rosuvastatin, anti-infective treatment, Extracorporeal Membrane Oxygenation(ECMO), stem cell therapy, Sedative analgesia/muscle relaxant therapy, Propofol, midazolam, dexmedetomidine, inotropes therapy, Dopamine, Olprinone, Levosimendan, Vasoactive drug therapy, Norepinephrine, epinephrine, metaraminol, isoproterenol
Second Affiliated Hospital, School of Medicine, Zhejiang University, Renmin Hospital of Wuhan University, The Second Affiliated Hospital of Harbin Medical University, West China Hospital, The First Affiliated Hospital of Zhengzhou University, Peking Union Medical College Hospital, Wuhan Union Hospital, China, Fudan University, Guangdong Provincial People's Hospital, Ningbo No. 1 Hospital, Taizhou Hospital of Zhejiang Province affiliated to Wenzhou Medical University
Acute Respiratory Distress Syndrome
10/23
12/23
NCT06153433: Clinical Trial to Evaluate the Efficacy and Safety of Suvaro®OD Tablet in Patients With Dyslipidemia

Recruiting
4
112
RoW
Rosuvastatin Immediate-Release Tablet (IRT) 10mg, Rosuvastatin orally disintegrating tablet (SUVARO®ODT) 10mg
Yonsei University
Dyslipidemia
07/24
08/24
EVALUATE-STEMI, NCT05613426: Effect of Very Early and Rapid Lowering Cholesterol With Evolocumab on Left Ventricular Remodeling in Patients With Anterior STEMI Undergoing Primary PCI

Recruiting
4
330
RoW
Rosuvastatin 20 mg, Evolocumab 140 mg/1 ml Subcutaneous Solution [REPATHA]
Henan Institute of Cardiovascular Epidemiology
ST Elevation Myocardial Infarction (STEMI)
12/23
12/24
ChiCTR2200055718: Effects of PCSK9 inhibitor therapy on fractional flow reserve in coronary borderline lesions

Recruiting
4
170
 
On the basis of conventional statin therapy, use Repatha subcutaneous injection to treat 1 vial of Q2W ;Atorvastatin 20mg/day or rosuvastatin 10mg/day
Tianjin Medical University General Hospital; Tianjin Medical University General Hospital, Suzhou Industrial Park Xinxin Cardiovascular Health Foundation
Coronary atherosclerosis
 
 
EItoCVP, NCT06338293: Effects of Inclisiran Combined With Statins on the Morphology of Coronary Vulnerable Plaques

Not yet recruiting
4
40
NA
Inclisiran sodium, Rosuvastatin
Nanjing First Hospital, Nanjing Medical University
Coronary Artery Disease
12/24
05/25
PREVESTATGx, NCT06262685: Efficacy, Safety and Cost-efficacy of a Pre-emptive Genotyping Strategy in Patients Receiving Statins

Not yet recruiting
4
216
Europe
Preemptive pharmacogenetic atorvastatin dose based on CPIC guidelines, Preemptive pharmacogenetic simvastatin dose based on CPIC guidelines, Preemptive pharmacogenetic pitavastatin dose based on CPIC guidelines, Preemptive pharmacogenetic rosuvastatin dose based on CPIC guidelines, Preemptive pharmacogenetic pravastatin dose based on CPIC guidelines, Preemptive pharmacogenetic lovastatin dose based on CPIC guidelines, Preemptive pharmacogenetic fluvastatin dose based on CPIC guidelines, Standard of Care (SoC) dosing of atorvastatin, Standard of Care (SoC) dosing of simvastatin, Standard of Care (SoC) dosing of pitavastatin, Standard of Care (SoC) dosing of rosuvastatin, Standard of Care (SoC) dosing of prasavastatin, Standard of Care (SoC) dosing of lovastatin, Standard of Care (SoC) dosing of fluvastatin
Instituto de Investigación Hospital Universitario La Paz, Instituto de Salud Carlos III
Cardiovascular Diseases, Dyslipidemias, Statin Adverse Reaction, Pharmacogenic Myopathy
02/25
03/25
INGEST, NCT04098003: Investigation of the Gut Microbiome and Statin Response

Active, not recruiting
4
62
US
Rosuvastatin, Crestor, Placebo
Sony Tuteja
Healthy Volunteers
06/24
06/24
NCT05747768: A Clinical Study to Evaluate the Pharmacokinetics of Microdose Midazolam, Dabigatran, Pitavastatin, Atorvastatin and Rosuvastatin in Healthy Volunteers and Renal Impairment Patients

Recruiting
4
60
RoW
Midazolam, dabigatran etexilate, pitavastatin, rosuvastatin and atorvastatin
Peking University Third Hospital
Chronic Kidney Disease
06/24
12/24
ChiCTR2300069104: Efficacy and safety analysis of PCSK9 inhibitors in patients with acute ischemic stroke caused by symptomatic intracranial atherosclerotic stenosis

Not yet recruiting
4
178
 
PCSK9i + atorvastatin calcium 20mg/ rosuvastatin calcium 10mg ;atorvastatin calcium 40mg/ rosuvastatin calcium 20mg
The Second Affiliated Hospital of Dalian Medical University; The Second Affiliated Hospital of Dalian Medical University, self funding
Ischemic cerebrovascular disease
 
 
PROACT 2, NCT05850091: Polygenic Risk-based Detection of Subclinical Coronary Atherosclerosis and Intervention With Statin and Colchicine

Recruiting
4
200
US
Rosuvastatin, Colchicine, Placebo
Massachusetts General Hospital, National Heart, Lung, and Blood Institute (NHLBI)
Coronary Artery Disease
07/26
07/27
2007-001493-91`ACTRN12609001027202: Heart Outcomes Prevention Evaluation (HOPE-3)

Completed
3/4
12705
Europe, RoW
Crestor, Atacand Plus, Tablet, Crestor
Population Health Research Institute, McMaster University/Hamilton Health Sciences, Population Health Research Institute (PHRI), McMaster University/Hamilton Health Sciences, University of Leicester, Population Health Research Institute,
Childbirth
 
 
2009-012850-19: Statins IN TREATMENT OF ACUTE coronary syndrome. COMPARISON OF EFFICACY BETWEEN Atorvastatin and Rosuvastatin IN PATIENTS UNDERGO A PTCA THROUGH THE MONITORING OF C REACTIVE PROTEIN

Ongoing
3
120
Europe
Tablet
AZIENDA SANITARIA LOCALE DI BARI
Patients with Acute coronary syndrome without up-leveling of ST line.
 
 
2020-001319-26: Clinical trial to assess the prognostic repercussions of rosuvastatin treatment in patients discharged after hospitalization for COVID-19 Positive. Ensayo clínico para evaluar las repercusiones en el pronóstico del tratamiento con rosuvastatina en pacientes dados de alta tras hospitalización por COVID-19 Positivo.

Ongoing
3
1080
Europe
Tablet
Instituto de Investigación Sanitaria Fundación Jiménez Díaz, Fundación Jiménez Díaz
COVID respiratory infection Infección respiratoria por COVID, Respiratory infection by Coronavirus Infección respiratoria por Coronavirus, Diseases [C] - Virus Diseases [C02]
 
 
2019-004208-37: Statins for treating ulcerative colitis through GI microbiome Statines voor de behandeling van ulceratieve colitis door middel van GI-microbioom

Not yet recruiting
3
400
Europe
rosuvastatin, Tablet, Rosuvastatine EG
UZ Leuven, Fonds Wetenschappelijk Onderzoek - Vlaanderen (FWO), Vlaamse Instituut Biotechnologie
There are two population groups, 20 healthy volunteers and at least 165 individuals diagnosed with IBD. Either with remission to mild/moderate active ulcerative colitis or remission to mild Crohn's disease., A bowel disease that are characterized by inflammation with ulcer formation in the lining of large intestine (UC) and/or rest of intestines (CD). Characterized by diarrhea and abdominal cramps., Diseases [C] - Digestive System Diseases [C06]
 
 
2021-005602-10: Study which will investigate, if the treatment with Inclisiran, Bempedoic acid and monoclonal antibodies Alirocumab or Evolocumab has other than lipid-lowering effects such as change in platelet activity and inflammation markers.

Not yet recruiting
3
60
Europe
Inclisiran, Nilemdo, Repatha, Rosuvastatin, Atorvastatin, Solution for injection in pre-filled syringe, Film-coated tablet, Leqvio, Nilemdo, Repatha, Rosuvastatin, Atorvastatin
Verein zur Förderung der Forschung auf dem Gebiet der Arteriosklerose, Thrombose und vaskulären Biologie (ATVB), Verein zur Fördferung der Forschung auf dem Gebiet der Arteriosklerose, Thrombose und vaskulären Biologie (ATVB)
platelet activity and inflammation markers in patients with coronary artery disease, platelet activity and inflammation markers in patients with coronary artery disease, Diseases [C] - Cardiovascular Diseases [C14]
 
 
STAR, NCT03037372: Statin Adjunct Therapy Among ART-treated Adults in Sub-Saharan Africa: Atorvastatin and Rosuvastatin Equivalence Trial

Not yet recruiting
3
320
NA
ART, Atorvastatin, Atovastatin adjunct therapy, ART, Rosuvastatin, Rosuvastatin adjunct therapy, ART, No statin, No statin adjunct therapy, Healthy-HIV-negative, HIV-negative controls
Makerere University, University of Oxford, Case Western Reserve University
HIV Infection
06/22
12/22
TACTiC, NCT04964544: Technology-Assisted Cholesterol Trial in Consumers

Completed
3
1196
US
5 mg rosuvastatin calcium with a Web App (combination product), Crestor 5 mg
AstraZeneca, Concentrics Research LLC, Concentrics Research - STATKING JV, Idea Evolver, The Cleveland Clinic
High Cholesterol
03/23
03/23
NCT03527069: Efficacy and Safety of Cipros 10 Association on the Isolated Hypertriglyceridemia and Dyslipidemia Treatment

Recruiting
3
298
RoW
Cipros 10 association, EMS association, Crestor 10 mg, Rosuvastatin 10 mg
EMS
Hypertriglyceridemia, Dyslipidemia
06/24
02/25
FlowPromote, NCT04737408: Influence of Intensive Lipid-lowering on FFRCT (The FLOW-PROMOTE Study)

Recruiting
3
120
Europe
Rosuvastatin 40mg, Ezetimib 10mg
Bjarne Linde Noergaard
Coronary Artery Disease
08/23
08/23
NCT05338723: Possible Protective Effect of Rosuvastatin in Chemotherapy-induced Cardiotoxicity in HER2 Positive Breast Cancer Patients

Completed
3
50
RoW
Rosuvastatin 20mg
Tanta University
Chemotherapy-induced Cardiotoxicity, Breast Cancer
09/23
09/23
NCT03540355: Efficacy and Safety of Cipros 20 Association on Dyslipidemia Treatment

Recruiting
3
312
RoW
Cipros 20 association, EMS Association, Crestor 20 mg, Rosuvastatin 20 mg
EMS
Dyslipidemias
11/23
02/24
NCT05731596: Comparative Clinical Study to Evaluate the Efficacy and Safety of Rosuvastatin Vs CoQ10 on Nonalcoholic Steatohepatitis

Not yet recruiting
3
46
NA
Rosuvastatin 20 Mg Oral Tablet, Coenzyme Q10 100 MG Oral Capsule
Tanta University
Nonalcoholic Steatohepatitis
02/24
04/24
NCT06358313: Concomitant Use of Clopidogrel With Atorvastatin or Rosuvastatin in Patients With Minor Stroke or TIA

Recruiting
3
600
RoW
Atorvastatin 40mg, group A, Rosuvastatin 20mg, group B
Kafrelsheikh University
Ischemic Stroke
04/25
05/25
NCT06360120: Combining Use of Clopidogrel With Atorvastatin or Rosuvastatin in Patients With Large-vessel Ischemic Stroke

Recruiting
3
600
RoW
Atorvastatin 40 Mg Oral Tablet, group A, Rosuvastatin 20mg, group B
Kafrelsheikh University
Ischemic Stroke
04/25
05/25
ChiCTR2200066956: Effect of intensive statin therapy on ventricular remodeling and cardiac function after PPCI in older STEMI patients

Recruiting
3
100
 
rosuvastatin, 20mg/d ;rosuvastatin, 10mg/d
QingPu Branch of Zhongshan Hospital, Fudan University; QingPu Branch of Zhongshan Hospital, Fudan University, Shanghai Municipal Health Commission
STEMI
 
 
NCT04603508: Efficacy and Safety of Berlim 25/10 Association in the Treatment of Type II Diabetes Mellitus and Dyslipidemia

Not yet recruiting
3
240
NA
BERLIM 25/10 association, EMPAGLIFLOZIN, ROSUVASTATIN CALCIUM, BERLIM 25/10 ASSOCIATION PLACEBO, EMPAGLIFLOZIN PLACEBO, ROSUVASTATIN CALCIUM PLACEBO
EMS
Type 2 Diabetes Mellitus, Dyslipidemia
04/25
08/25
NCT04602754: Efficacy and Safety of Berlim 25/20 Association in the Treatment of Type II Diabetes Mellitus and Dyslipidemia.

Recruiting
3
228
RoW
BERLIM 25/20 ASSOCIATION, EMPAGLIFLOZIN PLACEBO, ROSUVASTATIN CALCIUM PLACEBO, EMPAGLIFLOZIN, ROSUVASTATIN CALCIUM, BERLIM 25/20 ASSOCIATION PLACEBO
EMS
Dyslipidemia Associated With Type II Diabetes Mellitus
04/25
08/25
SAVER, NCT04319627: Statins for Venous Event Reduction in Patients With Venous Thromboembolism

Recruiting
3
2700
Europe, Canada
Rosuvastatin Calcium, Rosuvastatin, Placebo Oral Tablet, Placebo
Ottawa Hospital Research Institute
Venous Thromboembolism, Blood Clot, Post Thrombotic Syndrome
01/26
01/27
ACTRN12616001544460: Effect of Sublingual (under the tongue) Rosuvastatin/Crestor (cholesterol/statin medication) in reducing the side effects experienced in subjects with high cholesterol & a history of cardiovascular disease (heart attack, coronary artery disease) with a known statin intolerance.

Recruiting
2/3
20
 
Dr Gregory Szto , AusIndustry
coronary artery disease, Hyperlipidaemia, Diabetes, peripheral vascular disease
 
 
NCT03720067: Propranolol, Carvedilol and Rosuvastatin in the Prevention of Variceal Bleeding in Cirrhotic Portal Hypertension

Recruiting
2/3
80
RoW
Propranolol, Carvedilol, Rosuvastatin, Placebo
Universidade Federal do Rio de Janeiro
Cirrhosis, Portal Hypertension, Variceal Hemorrhage
12/20
12/22
2021-001559-15: Statins for reduction of recurrent venous thrombosis

Not yet recruiting
2/3
2700
Europe
Rosuvastatin calcium, Tablet
Ottawa Hospital Research Institute, The Canadian Institutes of Health Research (CIHR)
Patients who are verified to have had deep venous thrombosis and/orpulmonary embolism, Diseases [C] - Blood and lymphatic diseases [C15]
 
 
ReMiDy, NCT04883840: Drug Repurposing - Statins as Microbiota Modulating Agents in Ulcerative Colitis

Recruiting
2/3
220
Europe
Rosuvastatin 10mg
Universitaire Ziekenhuizen KU Leuven, Vlaams Instituut Biotechnologie (VIB)
Ulcerative Colitis
11/23
12/23
DECIST, NCT05565976: Dapagliflozin Effect in Cognitive Impairment in Stroke Trial

Recruiting
2/3
270
RoW
Dapagliflozin 10mg Tab, FORXIGA, Statins (Cardiovascular Agents), Atorvastatin, Pravastatin, Rosuvastatin, Platelet Antiaggregant, Clopidogrel, Acetylsalicylic acid, Antidiabetic, Sulfonylureas, Meglitinides, Biguanides, Thiazolidinediones, α-Glucosidase inhibitors, Inhibitors of dipeptidyl peptidase 4, Cycloset, Insulin glargine, Insulin lispro, Isophane insulin
Jaime Daniel Mondragon, Hospital General León, Hospital General de Zona IMSS N0. 21, University Medical Center Groningen
Stroke, Ischemic, Mild Cognitive Impairment, Dementia, Vascular, Metabolic Syndrome
12/24
07/25
2009-016737-95: ROSuvastatin Pretreatment during Carotid Artery Stenting Pretrattamento con Rosuvastatina durante Angioplastica Carotidea

Ongoing
2
130
Europe
Film-coated tablet
AZIENDA OSPEDALIERO-UNIVERSITARIA PISANA, DIPARTIMENTO CARDIOTORACICO E VASCOLARE UNIVERSITA' DI PISA
Asymptomatic carotid stenosis >80% in patients with baseline LDL cholesterol >120 mg/dL. Stenosi carotidea >80% asintomatica in pazienti con colesterolemia LDL >120 mg/dL., Carotid stenosis Stenosi carotidea, Diseases [C] - Cardiovascular Diseases [C14]
 
 
2006-000978-68: Treatment of systemic effects in patients with COPD

Ongoing
2
100
Europe
acetylcysteine, rosuvastatin,
AstraZeneca
Chronic obstructive pulmonary disease (COPD) is a preventable and treatable disease state characterized by airflow limitation that is not fully reverible. The airflow limitation is usually progressive and associated with an abnormal inflammatory response of the lungs to noxious particles or gases, primarily caused by cigarette smoking.
 
 
2012-002877-71: cGMP Enhancing Therapeutic Strategy for HFpEF: The cGETS Study An interventional, single blind, multicentre study. cGMP verhogende strategieën bij HFpEF: De cGETS Studie. Een interventionele, enkelblinde, multicentre studie.

Ongoing
2
25
Europe
Tritace, Tablet, Film-coated tablet, Capsule, Januvia, Cialis, Lipitor, Zestril, Crestor, Zocor, Coversyl, Tritace, Atacand, Nebilet
European Commission FP7 Health 2010, European Commission FP7 Health 2010
HFpEF patients over 18 years old and concomitant arterial hypertension, overweight or obesity and pulmonary hypertension. Patiënten met HFpEF die ouder zijn dan 18 jaar en tevens lijden aan arteriële hypertensie, overgewicht of obesitas en pulmonale hypertensie., Heart Failure with preserved Ejection Fraction in combination with a high blood pressure, high pulmonary blood pressure and overweight or obesity. Hartfalen met een bewaarde ejectiefractie met daarnaast een hoge bloeddruk, hoge longbloeddruk en overgewicht of zwaarlijvigheid., Diseases [C] - Cardiovascular Diseases [C14]
 
 
ROSETTA, NCT04504851: Rosuvastatin Evaluation as a Tuberculosis Treatment Adjunct

Not yet recruiting
2
154
RoW
Rosuvastatin 10mg, Crestor, Rifampicin, Isoniazid, Pyrazinamide, Ethambutol
National University Hospital, Singapore
Pulmonary Tuberculosis
03/21
03/21
NCT04817904: Evaluation of the Effect of Rosuvastatin on Cisplatin-induced Nephrotoxicity and Ototoxicity

Recruiting
2
65
RoW
Rosuvastatin 10mg
Cairo University, German University in Cairo
Cisplatin Adverse Reaction
08/21
08/21
NCT04303806: Effect of Rosuvastatin on the Clinical Features of Preeclampsia

Not yet recruiting
2
80
NA
rosuvastatin
Assiut University
Preeclampsia
10/22
12/23
RoBaCO, NCT03113994: Statin Monotherapy for Treatment of Endocrine Metabolic Disease Risk

Active, not recruiting
2
8
Canada, US
Rosuvastatin Calcium, Placebo Oral Tablet, Coenzyme Q10, Calcium Carbonate, Vitamin D
Dr. B. Catharine. Craven, The Craig H. Neilsen Foundation, Toronto Rehabilitation Institute, University Health Network, Toronto, University of Miami, Rick Hansen Institute
Spinal Cord Injuries, Osteoporosis, Metabolic Syndrome
12/22
12/22
NCT05895123: Comparison Between the Effects of High Doses Statin on Ventricular Remodeling in STEMI Patients

Completed
2
80
RoW
Rosuvastatin 20 mg ,40 mg, cholerose, Atorvastatin 40mg,80mg, ator
Damanhour University, Alexandria University
ST-segment Elevation Myocardial Infarction
03/23
04/23
NCT04491643: Megestrol Acetate Plus Rosuvastatin in Young Women With Early Endometrial Carcinoma

Recruiting
2
48
RoW
Megestrol Acetate, Rosuvastatin
Fudan University
Endometrial Carcinoma Stage I
08/25
08/25
NCT03532139: Pilot Study of Rosuvastatin and Enoxaparin Thromboprophylaxis Following Ovarian Cancer Surgery (O-STAT Study)

Active, not recruiting
2
24
US
Enoxaparin, Enoxaparin + Rosuvastatin, Thromboprophylaxis
Beth Israel Deaconess Medical Center, National Institutes of Health (NIH), National Heart, Lung, and Blood Institute (NHLBI)
Ovarian Cancer
12/23
05/24
SATBRAD, NCT04824911: Statin and Dual Antiplatelet Therapy to Prevent Early Neurological Deterioration in Branch Atheromatous Disease

Recruiting
2
424
RoW
Clopidogrel, Aspirin, Atorvastatin, Rosuvastatin
Chang Gung Memorial Hospital
Acute Stroke, Dual Antiplatelet Therapy, Statin
02/24
07/26
NCT06102863: Progesterone Therapeutic Regimen Plus Statins in Young Women With Early Endometrial Carcinoma and Atypical Endometrial Hyperplasia

Recruiting
2
38
RoW
statins (oral atorvastatin calcium tablet 20mg/ day; Or rosuvastatin 5mg/ day; Or pivastatin 2mg/ day);
Peking University People's Hospital
Atypical Endometrial Hyperplasia and Endometrial Carcinoma Stage I
12/24
02/25
LCN RESCU, NCT05832229: Liver Cirrhosis Network Rosuvastatin Efficacy and Safety for Cirrhosis in the United States

Recruiting
2
256
US
Rosuvastatin, Rosuvastatin 20 mg, Rosuvastatin 10 mg
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), The Cleveland Clinic, Columbia University, Weill Medical College of Cornell University, Duke University, Mayo Clinic, University of Miami, University of Michigan, University of California, San Diego, University of California, San Francisco, LAC+USC Medical Center, Virginia Commonwealth University, National Institute on Alcohol Abuse and Alcoholism (NIAAA), National Cancer Institute (NCI), University of Southern California
Cirrhosis, Cirrhosis, Liver, Cirrhosis Early, Cirrhosis Due to Hepatitis B, Cirrhosis Advanced, Cirrhosis Infectious, Cirrhosis Alcoholic, Cirrhosis, Biliary, Cirrhosis Cryptogenic, Cirrhosis Due to Hepatitis C, Cirrhosis Due to Primary Sclerosing Cholangitis
11/26
11/26
NCT05483010: Statins in Patients With Clonal Cytopenia of Undetermined Significance (CCUS) and Myelodysplastic Syndromes (MDS)

Recruiting
2
16
US
Atorvastatin, Lipitor, Rosuvastatin, Crestor
Washington University School of Medicine
Clonal Cytopenia of Undetermined Significance, Myelodysplastic Syndromes
05/27
05/27
NCT06048588: YN001 in Healthy Subjects and Patients With Coronary Atherosclerosis

Recruiting
1/2
130
RoW
YN001, Placebo for YN001, Placebo, rosuvastatin calcium tablets, Crestor®
Beijing Inno Medicine Co., Ltd.
Atherosclerotic Cardiovascular Disease
10/24
11/24
NCT04833764: Mechanisms of Deep Vein Thrombosis (DVT) and Vein Wall Fibrosis

Recruiting
1/2
30
US
Rosuvastatin
Khanh Nguyen
Post-thrombotic Syndrome, Deep Vein Thrombosis Leg
06/25
06/25
ACTRN12621000785808p: A Phase 1 Study to Evaluate the Effect of Itraconazole on the Pharmacokinetics of GS-5718 and to Evaluate the Effect of GS-5718 on the Pharmacokinetics of Rosuvastatin in Healthy Subjects

Not yet recruiting
1
32
 
Gilead Sciences, Gilead Sciences
Inflammatory Diseases
 
 
ACTRN12621000785808: A Phase 1 Study to Evaluate the Effect of Itraconazole on the Pharmacokinetics of GS-5718 and to Evaluate the Effect of GS-5718 on the Pharmacokinetics of Rosuvastatin in Healthy Subjects

Recruiting
1
32
 
Gilead Sciences, Gilead Sciences
Inflammatory Diseases
 
 
ChiCTR-IPR-15007014: Effect of Rosuvastatin (10mg/d) treatment of Nonalcoholic fatty liver disease (NAFLD) patients with Metabolic Syndrome (MS) but without diabetes evaluated by 1H-MRS: Exploratory study

Recruiting
1
20
 
rosuvastatin (10mg/d) * 52 weeks
Department of Endocrinology, Key Laboratory of Endocrinology, Ministry of Health, Peking Union Medical College Hospital, Peking Union Medical College, Chinese Academy of Medical Sciences; Department of Endocrinology, Key Laboratory of Endocrinology, Ministry of Health, Peking Union Medical College Hospital, Peking Union Medical College, Chinese Academy of Medical Sciences, AstraZeneca Investment (China) Co., Ltd
Nonalcoholic fatty liver disease(NAFLD)
 
 
ChiCTR-TTRCC-12002289: Pharmacokinetics study of rosuvastatin calcium tablets

Completed
1
48
 
oral ingestion of a single dose of rosuvastatin tablets (5mg) ;oral ingestion of a single dose of rosuvastatin tablets (10mg) ;oral ingestion of a single dose of rosuvastatin tablets (20mg) ;oral ingestion of a single dose of rosuvastatin tablets (10mg)
The Second Affiliated Hospital, School of Medicine, Zhejiang University; The Second Affiliated Hospital, School of Medicine,Zhejiang University, Zhejiang Yongning Pharmaceutical Company
Hypercholesterolemia (phase II); Phase I pharmacokinetics study(not involving disease)
 
 
ChiCTR-TTRCC-12002290: Investigations on relations between SNPs in statin-related transporters and metabolizing enzymes and pharmacokinetics of fluvastatin, simvastatin, rosuvastatin and pitavastatin

Completed
1
64
 
Retrospective analysis of pharmacokinetics data and collect 5ml blood for genotying ;Retrospective analysis of pharmacokinetics data and collect 5ml blood for genotying ;Retrospective analysis of pharmacokinetics data and collect 5ml blood for genotying ;Retrospective analysis of pharmacokinetics data and collect 5ml blood for genotying
The 2nd Affiliated Hospital, School of Medicine, Zhejiang University; The Second Affiliated Hospital, School of Medicine,Zhejiang University, Division of Clinical Pharmacology, The 2nd Affiliated Hospital, School of Medicine, Zhejiang University
not disease-related
 
 
ChiCTR-RCH-12002706: Role of BCRP 421C>A and 34G>A polymorphisms on rosuvastatin pharmacokinetics in healthy Chinese males and its molecular mechanism

Completed
1
72
 
Nil
Institute of Clinical Pharmacology, Central South University; Level of the institution:, National Natural Science Foundation of China
Hyperlipidemia
 
 
ChiCTR-RCH-12002823: analysis ABCG2 gene methylation and exporing its effects on pharmacokinetics of rosuvastatin

Completed
1
24
 
rosuvastatin
Institute of Clinical Pharmacology, Central South University; Institute of Clinical Pharmacology, Central South University, National Natural Science Foundation of China
Hyperlipidemia
 
 
ChiCTR-ONC-13003007: Interactions of herbs with statin drugs and potential mediation by drug transporters

Not yet recruiting
1
36
 
Simvastatin 20mg/ Rosuvastatin 10mg for 3 days and Green Tea Extract 400mg for 15 days
Chinese University of Hong Kong; Level of the institution:, Chinese University of Hong Kong
Healthy Volunteers
 
 
NCT02592317: A Study to Evaluate the Effect of Multiple Doses of JNJ-56021927 on the Pharmacokinetics of Multiple Cytochrome P450 and Transporter Substrates in Participants With Castration-Resistant Prostate Cancer

Recruiting
1
20
Europe, RoW
JNJ 56021927, Drug Cocktail, Pioglitazone, Rosuvastatin
Aragon Pharmaceuticals, Inc.
Prostatic Neoplasms, Castration-Resistant
11/16
12/24
ChiCTR1900021628: A Drug-drug Interaction(DDI) Study Of Yimitasvir And Rosuvastatin In Healthy Male Subjects

Not yet recruiting
1
14
 
Yimitasvir100mg+Rosuvastatin10mg
the First Hospital of Jilin University; the First Hospital of Jilin University, self-funding
chronic hepatitis C
 
 
NCT03864042: Pharmacokinetic Drug-drug Interaction Study of Encorafenib and Binimetinib on Probe Drugs in Patients With BRAF V600-mutant Melanoma or Other Advanced Solid Tumors

Active, not recruiting
1
56
Europe, Canada, US
losartan, dextromethorphan, caffeine, omeprazole, midazolam, rosuvastatin, bupropion immediate release (IR), encorafenib, binimetinib, modafinil
Pfizer, Pierre Fabre Laboratories
Advanced Solid Tumors, Metastatic Melanoma
07/22
06/23
NCT05594615: Drug-Drug Interaction Study Between EDP-235, Midazolam, Caffeine and Rosuvastatin in Healthy Subjects

Completed
1
24
US
EDP-235, Midazolam, Rosuvastatin, Caffeine
Enanta Pharmaceuticals, Inc
COVID-19
11/22
11/22
NCT05389722: A Study to Assess the Drug Levels of CC-92480 After Coadministration With Rifampin and Itraconazole, and the Drug Levels of Digoxin and Rosuvastatin After Coadministration With CC-92480 in Healthy Participants

Completed
1
24
US
CC-92480, BMS-986348, Rifampin, Itraconazole, Digoxin, Rosuvastatin
Bristol-Myers Squibb
Healthy Volunteers
11/22
11/22
NCT04887194: PK Study to Assess Drug-drug Interaction and QTc Between Sitravatinib and a Cocktail of Substrates

Completed
1
40
US
Sitravatinib, MGCD516, Warfarin, Coumadin, Dextromethorphan, Robitussin, Midazolam, Versed, Digoxin, LANOXICAPS, Rosuvastatin, Crestor, Nivolumab, OPDIVO
Mirati Therapeutics Inc.
Advanced Solid Tumor
12/22
12/22
KF2019#1, NCT05373277: -trial: Effects of a Thrombocyte Inhibitor on a Cholesterol-lowering Drug

Recruiting
1
10
Europe
Placebo, Ticagrelor, Rosuvastatin
Helsinki University Central Hospital, University of Helsinki
Pharmacokinetics
12/22
12/22
NCT05652660: A Study to Understand the Effect of a Study Medicine Called ARV-471 on Rosuvastatin in Healthy Adults

Completed
1
12
US
ARV-471, PF-07850327, Rosuvastatin, CRESTOR®
Pfizer, Arvinas Estrogen Receptor, Inc.
Healthy
03/23
03/23
NCT05708573: Potential Drug Interaction Between ALXN2040 and Rosuvastatin

Completed
1
20
US
Rosuvastatin, ALXN2040
Alexion
Healthy Participants
03/23
04/23
 

Download Options